Date	Period	Revenue/Estimate	Earnings Call
--	2026/Q1	-- / 166.720B	--
--	2025/Q4	-- / 165.762B	--
Jan 31, 2025	2025/Q3	346.836B / 165.492B	--
Nov 12, 2024	2025/Q2	128.032B / 165.598B	--
Jul 30, 2024	2025/Q1	669.098B / 196.500B	--

DatePeriodRevenue/EstimateEarnings Call

--2026/Q1-- / 166.720B--

--2025/Q4-- / 165.762B--

Jan 31, 20252025/Q3346.836B / 165.492B--

Nov 12, 20242025/Q2128.032B / 165.598B--

Jul 30, 20242025/Q1669.098B / 196.500B--

Unlock Free Earnings Estimates

Open Account

Sumitomo Mitsui Trust Group Earnings Reports

Sumitomo Mitsui Trust Group: Capital adequacy ratio for the 3rd quarter of the fiscal year ending 2025/3

Feb 13 02:00 ET

Sumitomo Mitsui Trust Group: Notice regarding revisions to consolidated earnings forecasts and dividend forecasts for the fiscal year ending March 31, 2025

Jan 31 02:00 ET

Sumitomo Mitsui Trust Group: Summary of Financial Results for the 3rd Quarter Ending March 31, 2025 [Japanese GAAP] (Consolidated)

Jan 31 02:00 ET

Sumitomo Mitsui Trust Group: Confirmation letter

Nov 27, 2024 20:34 ET

Symbol Price % Chg

D. Western Therapeutics Institute

4576